J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM.BO)
INR 1941.8
(4.63%)
INR 1941.8
(4.63%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 22.69 Billion INR | -21.13% |
| 2022 | 19.81 Billion INR | 25.28% |
| 2021 | 15.81 Billion INR | 19.34% |
| 2020 | 13.25 Billion INR | 21.74% |
| 2019 | 10.88 Billion INR | 10.06% |
| 2018 | 9.88 Billion INR | 20.29% |
| 2017 | 8.22 Billion INR | 8.46% |
| 2016 | 7.58 Billion INR | 12.87% |
| 2015 | 6.71 Billion INR | 17.08% |
| 2014 | 5.73 Billion INR | 13.88% |
| 2013 | 5.03 Billion INR | 25.02% |
| 2012 | 4.02 Billion INR | 2.95% |
| 2011 | 3.91 Billion INR | -32.68% |
| 2010 | 5.81 Billion INR | 19.37% |
| 2009 | 4.86 Billion INR | -31.53% |
| 2008 | 7.11 Billion INR | 28.38% |
| 2007 | 5.54 Billion INR | 5.26% |
| 2006 | 5.26 Billion INR | 11.65% |
| 2005 | 4.71 Billion INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 4.56 Billion INR | 24.17% |
| 2023 Q2 | 5.83 Billion INR | -0.45% |
| 2023 FY | 15.62 Billion INR | -21.13% |
| 2023 Q4 | 3.68 Billion INR | -35.54% |
| 2023 Q3 | 5.7 Billion INR | -2.17% |
| 2023 Q1 | 5.86 Billion INR | 20.26% |
| 2022 Q4 | 4.87 Billion INR | -1.26% |
| 2022 Q1 | 4.92 Billion INR | 25.74% |
| 2022 FY | 19.81 Billion INR | 25.28% |
| 2022 Q2 | 5.07 Billion INR | 3.22% |
| 2022 Q3 | 4.93 Billion INR | -2.79% |
| 2021 Q1 | 3.89 Billion INR | 38.44% |
| 2021 Q4 | 3.91 Billion INR | -0.84% |
| 2021 FY | 15.81 Billion INR | 19.34% |
| 2021 Q3 | 3.94 Billion INR | 2.37% |
| 2021 Q2 | 3.85 Billion INR | -1.02% |
| 2020 Q1 | 3.36 Billion INR | 39.39% |
| 2020 FY | 13.25 Billion INR | 21.74% |
| 2020 Q4 | 2.81 Billion INR | -22.14% |
| 2020 Q2 | 3.09 Billion INR | -7.82% |
| 2020 Q3 | 3.61 Billion INR | 16.66% |
| 2019 Q3 | 2.78 Billion INR | -3.94% |
| 2019 Q4 | 2.41 Billion INR | -13.37% |
| 2019 Q2 | 2.89 Billion INR | 3.7% |
| 2019 Q1 | 2.79 Billion INR | 41.72% |
| 2019 FY | 10.88 Billion INR | 10.06% |
| 2018 Q1 | 2.6 Billion INR | 0.0% |
| 2018 Q3 | 2.55 Billion INR | -7.32% |
| 2018 FY | 9.88 Billion INR | 20.29% |
| 2018 Q4 | 1.97 Billion INR | -22.89% |
| 2018 Q2 | 2.75 Billion INR | 5.95% |
| 2017 Q1 | 1.72 Billion INR | -10.56% |
| 2017 FY | 8.22 Billion INR | 8.46% |
| 2016 FY | 7.58 Billion INR | 12.87% |
| 2016 Q4 | 1.93 Billion INR | 0.0% |
| 2015 Q4 | 1.91 Billion INR | 0.0% |
| 2015 FY | 6.71 Billion INR | 17.08% |
| 2014 FY | 5.73 Billion INR | 13.88% |
| 2013 Q1 | 1.3 Billion INR | 0.0% |
| 2013 FY | 5.03 Billion INR | 25.02% |
| 2012 FY | 4.02 Billion INR | 2.95% |
| 2012 Q1 | 1.06 Billion INR | 0.0% |
| 2011 FY | 3.91 Billion INR | -32.68% |
| 2010 FY | 5.81 Billion INR | 19.37% |
| 2009 FY | 4.86 Billion INR | -31.53% |
| 2008 FY | 7.11 Billion INR | 28.38% |
| 2007 FY | 5.54 Billion INR | 5.26% |
| 2006 FY | 5.26 Billion INR | 11.65% |
| 2005 FY | 4.71 Billion INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Ajanta Pharma Limited | 21.06 Billion INR | -7.766% |
| Amrutanjan Health Care Limited | 1.55 Billion INR | -1358.363% |
| Sigachi Industries Limited | 2 Billion INR | -1033.7% |
| Bal Pharma Limited | 770.19 Million INR | -2847.291% |
| Ind-Swift Laboratories Limited | 6.19 Billion INR | -266.461% |
| Medico Remedies Limited | 262.14 Million INR | -8559.321% |
| Lasa Supergenerics Limited | 121.02 Million INR | -18655.59% |
| Venus Remedies Limited | 2.18 Billion INR | -940.046% |
| Sun Pharma Advanced Research Company Limited | -602.4 Million INR | 3868.204% |
| Alpa Laboratories Limited | 188.89 Million INR | -11917.2% |
| Nectar Lifesciences Limited | 2.97 Billion INR | -663.776% |
| Shilpa Medicare Limited | 3.54 Billion INR | -539.999% |
| Aarti Drugs Limited | 8.31 Billion INR | -172.96% |
| Lupin Limited | 123.71 Billion INR | 81.652% |
| Aurobindo Pharma Limited | 154.68 Billion INR | 85.325% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 81.871% |
| Windlas Biotech Limited | 1.33 Billion INR | -1595.54% |
| Suven Life Sciences Limited | -200.79 Million INR | 11404.895% |
| Eris Lifesciences Limited | 10.42 Billion INR | -117.707% |
| Valiant Laboratories Limited | -60.66 Million INR | 37519.046% |
| Solara Active Pharma Sciences Limited | 861.2 Million INR | -2535.844% |
| Ipca Laboratories Limited | 29.8 Billion INR | 23.851% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | -514.268% |
| Achyut Healthcare Limited | 4.86 Million INR | -466879.84% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 91.218% |
| Bajaj HealthCare Limited | 1.47 Billion INR | -1442.315% |
| RPG Life Sciences Limited | 2.48 Billion INR | -814.212% |
| Mankind Pharma Limited | 44.52 Billion INR | 49.013% |
| Laurus Labs Limited | 24.62 Billion INR | 7.799% |
| Piramal Pharma Limited | 24.47 Billion INR | 7.237% |
| Syncom Formulations (India) Limited | 942.39 Million INR | -2308.735% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | 51.452% |
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | 15.238% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 67.263% |
| Unichem Laboratories Limited | 4.86 Billion INR | -366.603% |
| Sequent Scientific Limited | 2.97 Billion INR | -662.066% |
| Novartis India Limited | 1.32 Billion INR | -1610.746% |
| Wanbury Limited | 1.73 Billion INR | -1211.645% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | -450.531% |
| Wockhardt Limited | 16.24 Billion INR | -39.778% |
| Themis Medicare Limited | 1.5 Billion INR | -1409.398% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | -3378.431% |
| Jubilant Pharmova Limited | 19.64 Billion INR | -15.562% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | -82.578% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 86.125% |
| Divi's Laboratories Limited | 32.44 Billion INR | 30.025% |
| NATCO Pharma Limited | 25.73 Billion INR | 11.797% |
| Gufic Biosciences Limited | 4.16 Billion INR | -444.662% |
| IOL Chemicals and Pharmaceuticals Limited | 4.58 Billion INR | -395.544% |
| Ind-Swift Limited | 2.17 Billion INR | -944.859% |
| Procter & Gamble Health Limited | 5.78 Billion INR | -292.637% |
| FDC Limited | 8.33 Billion INR | -172.353% |
| Krebs Biochemicals & Industries Limited | 192.72 Million INR | -11678.261% |
| Granules India Limited | 16.79 Billion INR | -35.124% |
| Medicamen Biotech Limited | 495.49 Million INR | -4481.255% |
| Alkem Laboratories Limited | 52.29 Billion INR | 56.594% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | -264.792% |
| Biofil Chemicals and Pharmaceuticals Limited | 14.57 Million INR | -155595.179% |
| Brooks Laboratories Limited | 65.62 Million INR | -34492.944% |
| Megasoft Limited | 342.07 Million INR | -6536.017% |
| ZIM Laboratories Limited | 1.26 Billion INR | -1691.785% |
| Strides Pharma Science Limited | 14.38 Billion INR | -57.768% |
| Neuland Laboratories Limited | 8.24 Billion INR | -175.222% |
| Morepen Laboratories Limited | 6.16 Billion INR | -268.428% |
| Hikal Limited | 3.14 Billion INR | -622.218% |
| Indoco Remedies Limited | 6.04 Billion INR | -275.744% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | -289.273% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | -3558.458% |
| Mangalam Drugs & Organics Limited | 703.6 Million INR | -3126.226% |
| Hester Biosciences Limited | 1.27 Billion INR | -1682.271% |